Coya Therapeutics, Inc. Common Stock (COYA) support and resistance · rev $7.9M
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
This page maps Coya Therapeutics, Inc. Common Stock (COYA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
COYA currently screens at market cap $118.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new COYA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the COYA quote page for the session range and the stock page for the full model.
Not investment advice.